Compound 9 (opioid antagonist)
![]() | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H21N3O2 |
| Molar mass | 347.418 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Compound 9 is a highly potent non-selective opioid antagonist. It blocks all three of the μ, δ and κ opioid receptors with highest affinity at μ and weakest at κ. It has been researched as a potential treatment agent for opioid overdose associated with highly potent opioids such as carfentanil, which often fails to respond to conventional antidotes such as naloxone due to its high binding affinity at the mu opioid receptor.[1][2]
See also
References
- ^ Takeuchi K, Holloway WG, McKinzie JH, Suter TM, Statnick MA, Surface PL, et al. (October 2007). "Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1". Bioorganic & Medicinal Chemistry Letters. 17 (19): 5349–5352. doi:10.1016/j.bmcl.2007.08.008. PMID 17720493.
- ^ Martin J, Onyameh E, Luo D, Powell JW, Trivedi RR, Woloshin EJ, et al. (June 2025). "Searching for Synthetic Opioid Rescue Agents. 2: Identification of an Ultra-Potent Synthetic Opioid Rescue Agent". Journal of Medicinal Chemistry. 68 (12): 13057–13074. doi:10.1021/acs.jmedchem.5c01108. PMC 12238956. PMID 40499097.
